The Effect of Soft Orthoses on Balance and Gait Performance in Children With Cerebral Palsy

July 26, 2021 updated by: Ehab Mohamed Abd El Kafy, Umm Al-Qura University

The Effect of Soft Orthoses and Strapping on Balance and Gait Performance in Children With Cerebral Palsy: A Randomized Controlled Trial

Most of the available studies that are relevant to motor rehabilitation for children with dyskinetic type of cerebral palsy are few and are comprised of small numbers of children. Further researches are necessary to explore new conservative therapeutic protocols and techniques that should contribute to control disorganized movement, handle postural asymmetry, maintain postural stability, and improve gait performance. Therefore, the objective of this study was to examine the effectiveness of soft orthosis and strapping system on balance, and gait performance in children with dyskinetic cerebral palsy.

Study Overview

Detailed Description

Dyskinetic type of cerebral palsy typically results from extrapyramidal and basal ganglia damage. The most common dyskinetic movement disorders are choreoathetosis and dystonia. Their clinical features include fluctuation of muscle tone, involuntary and in-coordinated movement, and posture instability. These features have significant negative impacts on the children's quality of life and performance of daily activities. Management strategy for children with dyskinesia requires both medical and rehabilitative treatment. Most of the available studies that are relevant to their motor rehabilitation are few and comprised of small numbers of children. The therapeutic modalities currently used for their rehabilitation require more evidence to certain their efficacy. Moreover, further researches are necessary to explore new conservative therapeutic protocols and techniques that should correct postural instability and improve the poor mobility of these children The objective of this study was to examine the effectiveness of an orthotic undergarment which is (TheraTog orthosis), and its strapping system on balance and gait performance in children with dyskinetic cerebral palsy.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mecca, Saudi Arabia, 21955
        • Umm Al Qura University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children of a confirmed diagnosis of dyskinetic cerebral palsy of choreoathetosis type were selected to participate in this study.
  • Children (of both sexes) were between 12 and 16 years old were included .
  • Their height and weight were more than 100 cm and 20 Kg respectively to be eligible for the evaluation process on the Biodex stability system.
  • Children were able to comprehend and follow orders.
  • Their gross motor development levels, as measured by Gross Motor Function Classification System, were between levels I and II.
  • Throughout the study period, participating children were not subjected to any other physical therapy programs except the assigned treatment protocol.

Exclusion Criteria:

  • Children were excluded from this study if they had inflexible spinal deformities interfering with spinal and limbs functional mobility.
  • Children were also excluded if their skin were sensitive or inflamed to any materials used.
  • Children who had seizures, perceptual disorders, visual problems, and auditory deficits did not participate as well.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
Children in the control group received the conventional physical therapy protocol which was designed to improve axial stability and trunk steadiness during standing and walking.
The conventional physical therapy protocol was designed to improve axial stability and trunk steadiness during standing and walking. The conventional therapeutic protocol for every child was 3 sessions/week for 12 consecutive weeks. Every treatment session was conducted for 2 hours with a 15-minutes rest between the two training hours.
Experimental: Study group
The children in the study group received the conventional protocol given to the control group. Moreover, they wore TheraTog orthotic undergarment with its strapping system eight hours every day for twelve consecutive weeks.
The conventional physical therapy protocol was designed to improve axial stability and trunk steadiness during standing and walking. The conventional therapeutic protocol for every child was 3 sessions/week for 12 consecutive weeks. Every treatment session was conducted for 2 hours with a 15-minutes rest between the two training hours.
TheraTog orthotic undergarment with its strapping system was applied for eight hours every day for twelve consecutive weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the Overall Stability Indices {percentage value (%)} for Postural Stability Test (test that assessed the change in postural stability)
Time Frame: Data was collected at baseline, and 12 weeks after intervention commencement.
The Biodex Balance System was used to assess the Change in the Overall Stability Indices of the Postural Stability Test. The test includes measurement of the following indices: overall stability index, anteroposterior index and mediolateral index which represents the children's ability to control their postural balance stability in all directions. High values % represent less stability and the children had difficulty in balance control. On the other hand lower values were indicative of a better balance control.
Data was collected at baseline, and 12 weeks after intervention commencement.
Change in the Pediatric Balance Scale score (scale that assessed the change in balance performance )
Time Frame: Data was collected at baseline, and 12 weeks after intervention commencement.
The Pediatric Balance Scale is a valid and reliable test to assess and re-assess balance deficits in children with mild and moderate motor disabilities. The test includes fourteen tasks that evaluate balance abilities and motor performance in children. 0-4 is the rating score for each item, where zero is the lowest score and 56 is the highest possible score for all tasks that indicate the best balance and motor performance ever.
Data was collected at baseline, and 12 weeks after intervention commencement.
Change in the gait parameter (step length) (This parameter indicated the change of gait performance).
Time Frame: Data was collected at baseline, and 12 weeks after intervention commencement.
An electronic walkway that connected to a portable computer was used to measure the following gait parameter: step length (cm).
Data was collected at baseline, and 12 weeks after intervention commencement.
Change in the gait parameter (gait cycle time) (This parameter indicated the change of gait performance).
Time Frame: Data was collected at baseline, and 12 weeks after intervention commencement.
An electronic walkway that connected to a portable computer was used to measure the following gait parameter: gait cycle time (seconds).
Data was collected at baseline, and 12 weeks after intervention commencement.
Change in the gait parameter (cadence) (This parameter indicated the change of gait performance).
Time Frame: Data was collected at baseline, and 12 weeks after intervention commencement.
An electronic walkway that connected to a portable computer was used to measure the following gait parameter: cadence (steps/ minute).
Data was collected at baseline, and 12 weeks after intervention commencement.
Change in the gait parameter (velocity) (This parameter indicated the change of gait performance).
Time Frame: Data was collected at baseline, and 12 weeks after intervention commencement.
An electronic walkway that connected to a portable computer was used to measure the following gait parameter: velocity (meter / second).
Data was collected at baseline, and 12 weeks after intervention commencement.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

February 1, 2021

Study Completion (Actual)

March 1, 2021

Study Registration Dates

First Submitted

July 18, 2021

First Submitted That Met QC Criteria

July 26, 2021

First Posted (Actual)

August 4, 2021

Study Record Updates

Last Update Posted (Actual)

August 4, 2021

Last Update Submitted That Met QC Criteria

July 26, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Conventional Physical Therapy Protocol

3
Subscribe